Mainat wrote:I am a fan of the otc so I had a quick look at the UAP vs Jubilee which I believe is a peer.
Based on 2011,
P/E is 8.2 vs ~5 for Jubilee which operates in a more liquid market. There is also over-performance on the year of listing. The upside is that you'll have 12 months to figure out if the numbers are good before the shares can even be listed at the NSE.
Would I buy? I like otc
@Mainat, are the returns of trading in OTC better than in NSE? I notice transaction costs in OTC are about same as those in NSE but the settlement period in OTC stretches to 2 months.
On UAP, Centum (an anchor shareholder) refused to sign lock up agreement meaning they plan to offload their holding in OTC. Other anchor shareholders have signed lock up for only 50% of their holding (page 39 of IM). Caution is called for here